Amgen

Employees’ Perception vs. Employers’ Reality! New Research Shows the Top 3 Areas of Opportunity
BioSpace
Mon, 10/14/19 - 09:30 am
Genentech
Pfizer
Merck
Amgen
Novartis
3 Drug Stocks Poised for Gains After Cancer Conference
Investopedia
Sun, 10/6/19 - 12:26 pm
ESMO
cancer
Amgen
Incyte
Bristol-Myers Squibb
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
Xconomy
Tue, 10/1/19 - 10:29 am
ESMO
PARP inhibitors
prostate cancer
KRAS
Seattle Genetics
AstraZeneca
Merck
GSK
Amgen
breast cancer
Roche
Pfizer
Colon cancer proves tougher target for Amgen's KRAS drug
Biopharma Dive
Sat, 09/28/19 - 04:43 pm
Amgen
colon cancer
ESMO
KRAS
The Week Ahead In Biotech: Spotlight On ESMO Conference
Yahoo/Benzinga
Sun, 09/22/19 - 11:10 pm
JNJ
daratumumab
Urogen
Rhythm Pharmaceuticals
Anavex
Aravive Biologics
TrovaGene
Incyte
AstraZeneca
Roche
Amgen
Aslan
G1 Therapeutics
GSK
Calithera Biosciences
Seattle Genetics
Immunomedics
Checkpoint Therapeutics
Aileron Therapeutics
Genocea Biosciences
AbbVie
Zymeworks
3 Biotechs With the Biggest Cash Stockpiles
Motley Fool
Fri, 09/20/19 - 09:27 am
biotech
cash
Gilead Sciences
Amgen
Celgene
Could Amgen's Latest Bad News Boost the Chances of More Acquisitions?
Fierce Pharma
Wed, 09/18/19 - 11:49 am
Amgen
M&A
AMG 397
Amgen's Kyprolis, J&J's Darzalex team up on myeloma survival win
Fierce Pharma
Mon, 09/16/19 - 09:25 am
Amgen
Kyprolis
JNJ
Darzalex
Multiple Myeloma
Amgen shares hit after analysts expose buried FDA trial halt
Fierce Biotech
Fri, 09/13/19 - 11:02 am
Amgen
AMG 397
clinical hold
FDA
clinical trials
AMG 176
Drug companies pay for exclusive access to UK genetic data
Biopharma Dive
Thu, 09/12/19 - 11:35 am
UK
genetic database
Amgen
AstraZeneca
JNJ
GSK
At Big Lung Cancer Meeting, Lights Shine on KRAS, Drug Combos & More
Xconomy
Mon, 09/9/19 - 08:08 pm
WCLC
lung cancer
KRAS
AMG 510
Amgen
RET
Merck
Keytruda
AstraZeneca
Imfinzi
Blueprint Medicines
Eli Lilly
What could help biotech close out 2019 stronger? Analysts pick 3 events to watch
Biopharma Dive
Sat, 09/7/19 - 06:38 pm
Amgen
AMG 510
KRAS inhibitors
Roche
PTC Therapeutics
risdiplam
Eylea
Novartis
[podcast+transcript]Why Amgen's Spending Billions to Buy This 1 Drug
Motley Fool
Sat, 09/7/19 - 06:16 pm
FTC
Amgen
Celgene
Bristol-Myers Squibb
M&A
Otezla
4 Biotech Stocks With Big Catalysts in September
Motley Fool
Thu, 09/5/19 - 10:14 pm
Amgen
AMG 510
Mirati Therapeutics
MRTX849
Eli Lilly
LOXO-292
Blueprint Me
Pralsetinibdicines
Amgen's Aimovig, under fire from Lilly, loses grip on CGRP share
Fierce Pharma
Thu, 09/5/19 - 10:37 am
Amgen
CGRPs
Aimovig
migraines
Eli Lilly
Emgality
Amgen’s ‘White Whale’ Cancer Data May Send Shares to Record High
Bloomberg
Wed, 09/4/19 - 10:20 am
Amgen
AMG 510
colon cancer
non-small cell lung cancer
Patent Challenge to Alexion Proceeds, But No Amgen Biosimilar Yet
Xconomy
Sat, 08/31/19 - 08:00 pm
patents
Alexion
Amgen
biosimilars
USPTO
Alexion shares slide on Amgen patent challenge to top-seller
Biopharma Dive
Fri, 08/30/19 - 01:00 pm
Amgen
Alexion
inter partes review
patents
Soliris
Sanofi, Regeneron score win against Amgen patents on PCSK9 med Repatha
Fierce Pharma
Wed, 08/28/19 - 10:52 pm
Sanofi
Regeneron
Amgen
PCSK9 inhibitors
patents
Praluent
Repatha
Yes, Amgen overpaid for Otezla—but that doesn't make it a mistake: analysts
Fierce Pharma
Wed, 08/28/19 - 12:47 pm
Amgen
Otezla
Enbrel
drug reps
M&A
Celgene

Pages